Neutrophil-activating therapy for the treatment of cancer
Cancer Cell2023Vol. 41(2), pp. 356–372.e10
Citations Over TimeTop 1% of 2023 papers
Ian L. Linde, Tyler R. Prestwood, Jingtao Qiu, Genay Pilarowski, Miles H. Linde, Xiangyue Zhang, Lei Shen, Nathan E. Reticker-Flynn, David Kung‐Chun Chiu, Lauren Y. Sheu, Simon Van Deursen, Lorna Tolentino, Wen‐Chao Song, Edgar G. Engleman
Related Papers
- → B7-H3/CD276: An Emerging Cancer Immunotherapy(2021)282 cited
- → New opportunities for nanoparticles in cancer immunotherapy(2018)214 cited
- → pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review(2020)95 cited
- → Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators(2020)80 cited
- → Nanotechnology-Based Bacterial Immunotherapy(2022)1 cited